Government officials hope to build a biotechnology industry with a production value of NT$150 billion (US$4.5 billion) by 2006 -- triple the current value.
Biotechnology is seen as an important part of an overall plan to develop industries meant to replace the information technology manufacturing companies migrating to China. Investment across the Taiwan Strait has risen as the economic downturn has forced companies to pare costs and boost profits.
The local biotech sector will have to grow by NT$50 billion every two years to meet the government's goal. The sector earned NT$49.5 billion for Taiwan last year, with products ranging from bio-chips and protein drugs to medical equipment, according to Alex Fang (
About NT$22.5 billion accounted for "pure" biotech products last year, while medical-equipment sales made up the remaining NT$27 billion.
Pharmaceutical products, which are treated as a separate category, reached NT$51.4 billion in sales last year, ministry statistics show.
The government has set aside NT$52 billion to develop the industry. NT$12 billion was spent last year to upgrade facilities at Academia Sinica and develop university programs, build research centers and attract talent. Over the next four years, the remaining NT$40 billion will be dispersed at a rate of NT$10 billion per year.
The Executive Yuan's Development Fund (開發基金) has also been tapped to help build a homegrown biotech industry by adding some NT$30 billion to the pockets of local venture capital firms, with incentives if they invest in local biotech start-ups.
The fund would be combined with NT$70 billion, which must be 30 percent government capital and 70 percent private, a Cabinet official said.
Any fund investing 20 percent of its total cash in a Taiwanese biotechnology company would be allowed to invest the remaining capital overseas, while funds investing in other sectors would be required to invest 50 percent locally and the remainder could be used abroad.
The Development Fund is charged with providing seed money for new industries, such as TFT-LCD panel production and semiconductor design. There are already 36 investments in the Development Fund portfolio.
In rival Singapore, the Business Times newspaper reported that the city-state has channeled more than US$700 million into biotech funds since 2000, including US$568 million for biomedical sciences and US$120 million for other initiatives.
Singapore's Agency of Science, Technology and Research has also allocated US$857 million for biotechnology R&D and another US$1.13 billion for biotech start-ups and overseas investments in the sector.
Intel Corp chief executive officer Lip-Bu Tan (陳立武) is expected to meet with Taiwanese suppliers next month in conjunction with the opening of the Computex Taipei trade show, supply chain sources said on Monday. The visit, the first for Tan to Taiwan since assuming his new post last month, would be aimed at enhancing Intel’s ties with suppliers in Taiwan as he attempts to help turn around the struggling US chipmaker, the sources said. Tan is to hold a banquet to celebrate Intel’s 40-year presence in Taiwan before Computex opens on May 20 and invite dozens of Taiwanese suppliers to exchange views
Application-specific integrated circuit designer Faraday Technology Corp (智原) yesterday said that although revenue this quarter would decline 30 percent from last quarter, it retained its full-year forecast of revenue growth of 100 percent. The company attributed the quarterly drop to a slowdown in customers’ production of chips using Faraday’s advanced packaging technology. The company is still confident about its revenue growth this year, given its strong “design-win” — or the projects it won to help customers design their chips, Faraday president Steve Wang (王國雍) told an online earnings conference. “The design-win this year is better than we expected. We believe we will win
Chizuko Kimura has become the first female sushi chef in the world to win a Michelin star, fulfilling a promise she made to her dying husband to continue his legacy. The 54-year-old Japanese chef regained the Michelin star her late husband, Shunei Kimura, won three years ago for their Sushi Shunei restaurant in Paris. For Shunei Kimura, the star was a dream come true. However, the joy was short-lived. He died from cancer just three months later in June 2022. He was 65. The following year, the restaurant in the heart of Montmartre lost its star rating. Chizuko Kimura insisted that the new star is still down
While China’s leaders use their economic and political might to fight US President Donald Trump’s trade war “to the end,” its army of social media soldiers are embarking on a more humorous campaign online. Trump’s tariff blitz has seen Washington and Beijing impose eye-watering duties on imports from the other, fanning a standoff between the economic superpowers that has sparked global recession fears and sent markets into a tailspin. Trump says his policy is a response to years of being “ripped off” by other countries and aims to bring manufacturing to the US, forcing companies to employ US workers. However, China’s online warriors
RSS